More targeted models, more explicit accountability and more technology-enabled oversight

The Centers for Medicare & Medicaid Services (CMS) rarely makes headlines by doing less. But the CMS Innovation Center’s 2025 – 2026 portfolio reset is notable precisely because it does: fewer programs, sharper requirements and a clearer expectation that participants deliver measurable savings, not just improved processes or care coordination on paper.

Established under the Affordable Care Act in 2010, the Center for Medicare and Medicaid Innovation (Innovation Center) tests innovative payment and service delivery models that reduce costs while maintaining or improving care quality. Since 2011, CMS has obligated US$11.4 billion to the Innovation Center and tested 70 models, of which 24 were active as of January 2025, according to a report by the US Government Accountability Office (GAO). By 2026, the active portfolio has narrowed considerably as CMS winds down older pilots and shifts toward a new cohort of models centered on chronic care management and bundled payment.

Over the past year, the Innovation Center has ended several prominent programs ahead of schedule, launched a new mandatory hospital model and deployed artificial intelligence (AI) in claims review. These are not incremental adjustments. Together, they signal a higher bar for providers and participants, with potentially serious financial and operational consequences for organizations that are not adequately prepared.

These moves also reflect a broader shift in how the Innovation Center defines success. Where earlier approaches emphasized experimentation, the current framework places greater weight on demonstrating savings for federal taxpayers. GAO reports that the Innovation Center is formalizing its performance tracking through clearer goals and metrics for model testing. In May 2025, it established long-term goals articulating its strategic vision, paired with near-term targets, measures and time frames that CMS plans to use to monitor progress and assess outcomes.

What has changed and why it matters

In March 2025, CMS announced the early termination of four models: Primary Care First, Making Care Primary, Maryland Total Cost of Care and End-Stage Renal Disease (ESRD) Treatment Choices. Making Care Primary ended June 30, 2025; the remaining three concluded by December 31, 2025, with the ESRD Treatment Choices termination formalized in the CY 2026 ESRD PPS final rule. CMS projected the terminations would generate nearly US$750 million in savings.

In May 2025, CMS recast its strategic direction around three priorities: evidence-based prevention, patient empowerment and choice and competition. Central to that framework is an explicit commitment to protecting federal taxpayers through risk-bearing models designed to promote high-value care and equitable use of funds. Future models, CMS has signaled, will place greater weight on downside financial risk and reductions in unnecessary utilization, yielding a smaller, more demanding portfolio oriented toward measurable savings.

This reset is not a wholesale abandonment of primary care, nor a simple pivot to mandatory specialty care programs. Rather, CMS is narrowing its portfolio to models with clearer savings logic, more defined provider obligations and clearer policy goals while keeping primary care and accountable care as the foundation. As of January 2026, an estimated 14.3 million Medicare beneficiaries receive care through accountable care organizations (ACOs) and related models, a foundation CMS plans to expand with Long-term Enhanced ACO Design (LEAD), a new 10-year voluntary ACO model set to launch in 2027.

Four directional shifts

CMS will mandate participation when it wants broad behavioral change

The TEAM (Transforming Episode Accountability) model departs from the Innovation Center's earlier voluntary approach by making participation mandatory for acute care hospitals in CMS-selected geographic markets. Operationally, TEAM retains fee-for-service billing with retrospective reconciliation against target prices, but it is more prescriptive than earlier voluntary episode models. Finalized in the FY 2025 IPPS final rule, TEAM holds hospitals accountable for total cost of care across five surgical episode categories through 30 days post-discharge, and runs from January 1, 2026, through December 31, 2030.

For providers in mandatory markets, 30-day episode performance becomes core operations, not a pilot exercise. Strong performers will likely standardize discharge-to-follow-up pathways, actively manage post-acute referrals and monitor readmissions and unwarranted utilization variation in near real time. The broader signal is that CMS is using mandatory scale to accelerate behavior change where it believes the savings case is sufficiently mature.

CMS is extending its use of AI as an oversight tool

The WISeR (Wasteful and Inappropriate Service Reduction) model is the most visible example of CMS's turn toward technology-enabled oversight in 2026. A six-year voluntary model running from January 1, 2026, through December 31, 2031, across six states (Arizona, New Jersey, Ohio, Oklahoma, Texas and Washington), WISeR uses AI and machine learning to flag selected services for potential waste, fraud, abuse or clinically unsupported utilization.

Rather than relying on CMS staff or Medicare Administrative Contractors (MACs) directly, WISeR engages technology-enabled companies with clinician-led review expertise to assess the medical necessity of certain Medicare services through either prior authorization or post-service, pre-payment medical review. These participants operate by MAC jurisdiction, share in savings from avoided unnecessary care based on performance and are accountable for minimizing administrative burden. Providers may elect prior authorization or face pre-payment review, with strong compliance potentially earning a "gold card" exemption from future reviews.

Narrower than some early coverage suggested, WISeR does not change Medicare coverage or payment policy, and any recommendation for non-payment must come from a licensed human clinician. The near-term reality is targeted, reviewable oversight, not fully automated claim denials. The direction, however, is significant: CMS is testing whether earlier, technology-supported claims review can generate savings without formally rewriting coverage rules.

For providers, WISeR means earlier and more frequent scrutiny of claims and documentation, even where coverage policy is unchanged. Readiness requires tight coverage-criteria discipline, stronger internal audit and appeal workflows and clinical leadership capable of responding quickly when claims are flagged. The model is, in effect, CMS's proof-of-concept for technology-enabled review as a scalable savings lever, and providers in the six participating states should treat it accordingly.

CMS is using voluntary models to build new markets

The ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) voluntary model reflects a different strategy. Rather than mandating participation or layering claims review on top of existing workflows, CMS is using ACCESS to build a scalable chronic-care market by defining clinical tracks, setting common outcome targets and tying payment to those targets through predictable monthly amounts, a deliberate shift, in CMS's framing, from paying for service volume to paying for measurable improvement.

ACCESS is organized around four clinical tracks: early cardio-kidney-metabolic (eCKM), cardio-kidney-metabolic (CKM), musculoskeletal and behavioral health that together affect more than two-thirds of Medicare beneficiaries. Payment is structured as monthly installments, with CMS withholding 50 percent of the Medicare portion of the annual outcome-aligned payment amount and reconciling that withhold after each 12-month care period. Organizations earn the full Medicare portion only if at least 50 percent of aligned beneficiaries who meet assessment criteria achieve all required clinical benchmarks. For many primary care practices without the scale or infrastructure to participate directly, the more immediate role is likely referral and co-management.

CMS also signaled that ACCESS is designed to reach beyond Medicare. Plans for public outcomes reporting, rising performance standards over time and alignment with private payers representing roughly 165 million covered lives are all intended to make the model's outcome measures and payment approach portable across payers, effectively using Medicare as the foundation for a broader, more consistent chronic-care market.

ACCESS has drawn strong early interest, with more than 150 organizations accepted into the 10-year program subject to final participation requirements. CMS extended the initial application deadline to May 15, 2026, for a July 5 launch, with later applicants entering January 1, 2027. For organizations pursuing participation, the readiness bar is meaningful: credible clinical governance, interoperable data infrastructure and outcomes reporting capable of withstanding external review, alongside the expected Medicare participation and compliance prerequisites. ACCESS is paying for execution, and the program's design leaves little room for organizations that are not operationally prepared.

Longitudinal accountability remains the foundation

Despite these new episode and oversight models, the Innovation Center’s portfolio remains anchored in long-term accountable care. The models below illustrate that the current direction reflects tightening, not retreat.

LEAD launches in January 2027 as ACO REACH concludes, and is designed to attract a broader range of providers than its predecessor, including smaller, independent, rural and specialty-focused practices, through improved benchmarking methodology. The model offers a 10-year test period without rebasing, running from January 1, 2027, through December 31, 2036, with particular emphasis on sustainable savings and stronger care coordination for high-needs populations, including dually eligible and homebound beneficiaries.

AHEAD (Achieving Healthcare Efficiency through Accountable Design) operates as a voluntary state total cost of care model,  aimed at driving healthcare transformation and multi-payer alignment at the state and sub-state-regional level, with the goal of improving population health while reducing overall costs. Six states participate across three cohorts: Maryland (Cohort 1), Connecticut, Hawaii and Vermont (Cohort 2), and Rhode Island and New York (Cohort 3). Maryland transitioned into performance in January 2026; Cohorts 2 and 3 begin performance in 2028. All cohorts run through December 31, 2035.

What does this mean for providers?

For most of its history, the Innovation Center was defined by breadth, heavy reliance on voluntary participation and a policy narrative that emphasized care redesign over measurable savings. The 2025 – 2026 reset signals a materially different operating model: fewer active programs, more prescriptive requirements and a clear expectation that models demonstrate taxpayer savings on a tighter timeline.

Across the portfolio, CMS is optimizing for scale and enforceability, not just innovation. Mandatory episodes (TEAM), technology-assisted claims review (WISeR) and market-building voluntary chronic care (ACCESS) point to a common theme: CMS is concentrating its tests on areas where it believes the savings logic is mature and the administrative levers are strong enough to drive behavior change.

Going forward, CMS is likely to organize its portfolio into distinct lanes: accountable care, specialty episodes, technology-enabled chronic care and targeted oversight, each with concrete expectations for savings and performance.

For providers, the strategic question is less which new model to join, and more which organizational capabilities CMS consistently rewards across all of them: responsibility for total cost and outcomes, interoperable data exchange, precise compliance with coverage criteria and demonstrable value in defined patient populations. Health systems, physician groups and digital health companies should evaluate their readiness through that lens.

The Norton Rose Fulbright team continues to monitor developments from the CMS Innovation Center. For questions about healthcare payment or service delivery models, please contact us.

Contact